Clinical Trial Update: Phase I Study of Surface-Controlled Water Soluble Curcumin (THERACURMIN CR-011L) [Phase 1]

View source ↗

Summary

Phase I study of surface-controlled water soluble curcumin THERACURMIN CR-011L in patients with advanced cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• THERACURMIN CR-011L (curcumin)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Advanced Cancers | Phase 1 | Status: COMPLETED